248 related articles for article (PubMed ID: 31768869)
1. Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients.
Mohammadrezakhani H; Baradaran B; Shanehbandi D; Asadi M; Hashemzadeh S; Hajiasgharzadeh K; Safaralizadeh R
J Gastrointest Cancer; 2020 Sep; 51(3):952-956. PubMed ID: 31768869
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
Cui H; Zhao J
J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
[TBL] [Abstract][Full Text] [Related]
4.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
Jin Y; Jiang A; Sun L; Lu Y
BMC Cancer; 2024 Feb; 24(1):238. PubMed ID: 38383342
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TMPO-AS1 facilitates the progression of colorectal cancer cells via sponging miR-98-5p to upregulate BCAT1 expression.
Ye J; Yan Y; Xin L; Liu J; Tang T; Bao X
J Gastroenterol Hepatol; 2022 Jan; 37(1):144-153. PubMed ID: 34370878
[TBL] [Abstract][Full Text] [Related]
10. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.
Chang H; Yao Y
Bioengineered; 2022 Feb; 13(2):2889-2901. PubMed ID: 35040749
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
Peng X; Yan J; Cheng F
Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TPT1-AS1 promotes the progression and metastasis of colorectal cancer by upregulating the TPT1-mediated FAK and JAK-STAT3 signalling pathways.
Zhang L; Ye F; Zuo Z; Cao D; Peng Y; Li Z; Huang J; Duan L
Aging (Albany NY); 2021 Jan; 13(3):3779-3797. PubMed ID: 33428595
[TBL] [Abstract][Full Text] [Related]
15. TMPO-AS1 is an independent prognostic factor for patients with laryngeal squamous cell carcinoma.
Zhang L; Zhang Y; Zhang C; Hou Y; Tian F
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):784-788. PubMed ID: 32696866
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZEB1-AS1 expression predicts progression and poor prognosis of colorectal cancer.
Fu J; Cui Y
Int J Biol Markers; 2017 Oct; 32(4):e428-e433. PubMed ID: 28967064
[TBL] [Abstract][Full Text] [Related]
17. Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
Tian Y; Zhou J; Zou Y; Luo B; Liu Q; Cao X
Anticancer Drugs; 2021 Jan; 32(1):66-73. PubMed ID: 32932277
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT.
Rezanejad Bardaji H; Asadi MH; Yaghoobi MM
Eur J Cell Biol; 2018 May; 97(4):279-288. PubMed ID: 29656793
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
